The Brian Allman Diffuse Large B Cell Lymphoma (DLBCL) Novel Therapeutics Program

Le Havre Flowers

Inspiration Brian lives by

The Brian Allman Diffuse Large B Cell Lymphoma (DLBCL) Novel Therapeutics Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.


Guidestar Platinum Seal of Transparency 2021


Federal Tax I.D.: EIN 86-0818253